AI-Driven Discovery of Safe, Tumor-Specific Immunotherapies Through the Lenses of RNA Splicing
Time: 1:00 pm
day: Day Two
Details:
- Using AI to analyze RNA-seq data and prioritize neoepitopes encoded by tumor-specific splicing isoforms
- Delve into the use of biopsies from different cohorts of patients with tumor vs. normal tissues to avoid off-target effects
- Validated novel neoepitopes predicted with AI through a case study in triple negative breast cancer
